Download
fimmu-12-696370.pdf 1,69MB
WeightNameValue
1000 Titel
  • Antibody Mediated Immunity to SARS-CoV-2 and Human Coronaviruses: Multiplex Beads Assay and Volumetric Absorptive Microsampling to Generate Immune Repertoire Cartography
1000 Autor/in
  1. Wang, Jiong |
  2. Li, Dongmei |
  3. Zhou, Qian |
  4. Wiltse, Alexander |
  5. Zand, Martin S. |
1000 Verlag
  • Frontiers Media S.A.
1000 Erscheinungsjahr 2021
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2021-07-27
1000 Erschienen in
1000 Quellenangabe
  • 12:696370
1000 Copyrightjahr
  • 2021
1000 Embargo
  • 2022-01-29
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.3389/fimmu.2021.696370 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8353270/ |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Abstract/Summary
  • <jats:p>The COVID-19 pandemic is caused by SARS-CoV-2, a novel zoonotic coronavirus. Emerging evidence indicates that preexisting humoral immunity against other seasonal human coronaviruses (HCoVs) plays a critical role in the specific antibody response to SARS-CoV-2. However, current work to assess the effects of preexisting and cross-reactive anti-HCoVs antibodies has been limited. To address this issue, we have adapted our previously reported multiplex assay to simultaneously and quantitatively measure anti-HCoV antibodies. The full mPlex-CoV panel covers the spike (S) and nucleocapsid (N) proteins of three highly pathogenic HCoVs (SARS-CoV-1, SARS-CoV-2, MERS) and four human seasonal strains (OC43, HKU1, NL63, 229E). Combining this assay with volumetric absorptive microsampling (VAMS), we measured the anti-HCoV IgG, IgA, and IgM antibodies in fingerstick blood samples. The results demonstrate that the mPlex-CoV assay has high specificity and sensitivity. It can detect strain-specific anti-HCoV antibodies down to 0.1 ng/ml with 4 log assay range and with low intra- and inter-assay coefficients of variation (%CV). We also estimate multiple strain HCoVs IgG, IgA and IgM concentration in VAMS samples in three categories of subjects: pre-COVID-19 (n=21), post-COVID-19 convalescents (n=19), and COVID-19 vaccine recipients (n=14). Using metric multidimensional scaling (MDS) analysis, HCoVs IgG concentrations in fingerstick blood samples were well separated between the pre-COVID-19, post-COVID-19 convalescents, and COVID-19 vaccine recipients. In addition, we demonstrate how multi-dimensional scaling analysis can be used to visualize IgG mediated antibody immunity against multiple human coronaviruses. We conclude that the combination of VAMS and the mPlex-Cov assay is well suited to performing remote study sample collection under pandemic conditions to monitor HCoVs antibody responses in population studies.</jats:p>
1000 Sacherschließung
lokal preexisting human coronavirus immunity
gnd 1206347392 COVID-19
lokal Antibodies, Viral/immunology [MeSH]
lokal anti-S and anti-N antibodies
lokal COVID-19/immunology [MeSH]
lokal Immunoglobulin M/immunology [MeSH]
lokal Coronavirus/immunology [MeSH]
lokal Immunoglobulin A/blood [MeSH]
lokal cross-reactive antibody immunity
lokal human coronaviruses (HCoVs)
lokal Coronavirus OC43, Human/immunology [MeSH]
lokal SARS-CoV-2/immunology [MeSH]
lokal mPlex-CoV assay
lokal volumetric absorptive micro-sampling (VAMS)
lokal Coronavirus Nucleocapsid Proteins/immunology [MeSH]
lokal Immunoglobulin A/immunology [MeSH]
lokal SARS-CoV-2
lokal Coronavirus 229E, Human/immunology [MeSH]
lokal Antibodies, Viral/blood [MeSH]
lokal Coronavirus NL63, Human/immunology [MeSH]
lokal Immunology
lokal Immunoglobulin M/blood [MeSH]
lokal Cross Reactions/immunology [MeSH]
lokal Humans [MeSH]
lokal COVID-19 vaccine studies
lokal Severe acute respiratory syndrome-related coronavirus/immunology [MeSH]
lokal Immunoglobulin G/immunology [MeSH]
lokal Immunoassay/methods [MeSH]
lokal Betacoronavirus/immunology [MeSH]
lokal Spike Glycoprotein, Coronavirus/immunology [MeSH]
lokal Immunoglobulin G/blood [MeSH]
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/V2FuZywgSmlvbmc=|https://frl.publisso.de/adhoc/uri/TGksIERvbmdtZWk=|https://frl.publisso.de/adhoc/uri/WmhvdSwgUWlhbg==|https://frl.publisso.de/adhoc/uri/V2lsdHNlLCBBbGV4YW5kZXI=|https://frl.publisso.de/adhoc/uri/WmFuZCwgTWFydGluIFMu
1000 Hinweis
  • DeepGreen-ID: 8add97fca72c4fbf8d4427ce168b6d35 ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Förderer
  1. National Institutes of Health |
1000 Fördernummer
  1. -
1000 Förderprogramm
  1. -
1000 Dateien
1000 Förderung
  1. 1000 joinedFunding-child
    1000 Förderer National Institutes of Health |
    1000 Förderprogramm -
    1000 Fördernummer -
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6478969.rdf
1000 Erstellt am 2024-05-21T18:49:31.003+0200
1000 Erstellt von 322
1000 beschreibt frl:6478969
1000 Zuletzt bearbeitet Wed May 22 12:18:29 CEST 2024
1000 Objekt bearb. Wed May 22 12:18:29 CEST 2024
1000 Vgl. frl:6478969
1000 Oai Id
  1. oai:frl.publisso.de:frl:6478969 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source